[Contribution to a study of a new lipolytic and anorectic drug: fenproporex (author's transl)].
D000273:Adipose Tissue / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D000661:Amphetamine / Q000627:therapeutic use; D000662:Amphetamines; D001067:Appetite Depressants / Q000627:therapeutic use*; D002648:Child; D004038:Diet, Reducing; D004232:Diuretics / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D009765:Obesity / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D014815:Vitamins / Q000627:therapeutic use
D000662:Amphetamines; D001067:Appetite Depressants; D004232:Diuretics; D005230:Fatty Acids, Nonesterified; D009570:Nitriles; D014815:Vitamins; D000661:Amphetamine
Contribución al estudio de un nuevo fármaco lipolítico anorexígeno: el fenproporex